SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-10-063090
Filing Date
2010-12-16
Accepted
2010-12-16 16:43:13
Documents
3
Period of Report
2010-12-14
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a10-23010_28k.htm 8-K 36990
2 EX-99.1 a10-23010_2ex99d1.htm EX-99.1 13457
3 GRAPHIC g230102mci001.gif GRAPHIC 5046
  Complete submission text file 0001104659-10-063090.txt   59481
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 500 SEATTLE WA 98119-4114
Business Address 7000 SHORELINE COURT SUITE 270 SO. SAN FRANCISCO CA 94080 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 101257275
SIC: 2834 Pharmaceutical Preparations